Schedule 13G ownership disclosure

Palisade Bio, Inc.

Common Stock, par value $0.01 per share · CUSIP: 696389402

Event date: 2025-10-01

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Commodore Capital LP

    Shares: 9,690,665.00 · Class: 9.9%

  • Commodore Capital Master LP

    Shares: 9,690,665.00 · Class: 9.9%

  • Robert Egen Atkinson

    Shares: 9,690,665.00 · Class: 9.9%

  • Michael Kramarz

    Shares: 9,690,665.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001831942-25-000021
Form type
SCHEDULE 13G
Filer
Commodore Capital LP
CIK
CIK 1831942
Filed
Oct 08, 2025
Reporting period
Oct 01, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub